loader
Please Wait
Applying Filters...
Close
4

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Sitagliptin Phosphate

    Client Email Product
    Menu

    Sitagliptin Phosphate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    PharmaCompass Sponsored Ads

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MERCK SHARP DOHME (18)

    02 MSD SUB MERCK (24)

    03 ZYDUS (3)

    filter

    01 7326708 (16)

    02 8080580 (2)

    03 8414921 (2)

    04 9308204 (2)

    05 9439901 (2)

    06 10925871 (3)

    07 7326708*PED (16)

    08 8414921*PED (2)

    filter

    01 Y (18)

    02 Blank (27)

    filter

    01 Y (25)

    02 Blank (20)

    filter

    01 2026-04-11 (6)

    02 2026-10-11 (6)

    03 2026-11-24 (10)

    04 2027-05-24 (10)

    05 2028-07-21 (2)

    06 2029-01-21 (2)

    07 2030-07-13 (2)

    08 2030-10-21 (4)

    09 2035-02-25 (3)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-11-24
    U-802
    21995
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-11-24
    U-802
    21995
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SIMVASTATIN; SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-04-11
    U-1188
    202343
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
    6
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708
    Y
    Y
    2026-11-24
    U-802
    21995
    METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    MERCK SHARP DOHME

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SITAGLIPTIN PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    7326708*PED
    2027-05-24
    21995
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY